Letter. The recent meta‐analytic review of trials involving anti‐inflammatory agents to treat or to supplement treatment of patients with major depressive disorder (MDD) or depressive symptoms by Köhler‐Forsberg and colleagues [1] includes data derived from 36 controlled trials.